The Partnership for Safe Medicines
SafeMeds Alert
FDA MedWatch Alert
June 15, 2009
FDA Warns Public About Stolen Levemir Insulin
Novo Nordisk product previously reported as stolen in North Carolina has resurfaced recently at a medical center in Houston.

FDA notified patients and healthcare professionals that some stolen vials of the long-acting insulin Levemir made by Novo Nordisk Inc. are being sold in the U.S. market, may not have been stored and handled properly, and may be dangerous for patients to use. The agency is advising patients who use Levemir insulin to:

Check your personal supply of insulin to determine if you have Levemir insulin from one of the following lots: XZF0036, XZF0037, and XZF0038. 

Do not use your Levemir insulin if it is from one of these lots.
Always visually inspect your insulin before using it. Levemir is a clear and colorless solution.

Contact the Novo Nordisk Customer Care Center at 1-800-727-6500 for what to do with vials from these lots or if you have any other questions.

Tom Kubic, president of PSI and officer of PSM, noted that "it's been over four months since the original theft in February 2009.  So who knows where or how these stolen medicines were stored while they made their way from North Carolina to the Houston medical facility. But one thing is certain, they weren't handled the way Novo Nordisk would have maintained them."


Manufacturer Inquires
Novo Nordisk Customer Care

Media Inquiries - HHS
Judy Leon 301-796-4624

Quick Links
About the SafeMeds Alert System
As part of the FDA's Alert Network, the SafeMeds Alert System is a free service that sends official alerts from the FDA and other government agencies around the world to anyone-private citizens, public groups, corporations, associations-when specific counterfeit drug incidents occur.

The SafeMeds Alert System is a service of the Partnership for Safe Medicines-a group of organizations and individuals that have policies, procedures, or programs to protect consumers from counterfeit or contraband medicines.  For more information, please visit